What You Should Know:
– RapidAI, the pioneer in Deep Clinical AI and intelligent imaging, has announced a major strategic partnership and co-development agreement with Saudi Health Holdings Company (HHC), the largest healthcare provider in the Middle East.
– The collaboration names RapidAI as HHC’s enterprise provider of deep clinical AI, which will be implemented across HHC’s vast network of 20 health clusters spanning all regions of the Kingdom of Saudi Arabia. The technology will support improved outcomes across multiple critical disease states, including neurology, cardiology, vascular, oncology, and orthopedic services.
Pillar of Saudi Vision 2030 Transformation
The partnership is a key pillar of HHC’s digital transformation strategy, directly supported by the Health Sector Transformation Program—one of Saudi Arabia’s Vision 2030 programs. The program’s objectives are to advance healthcare quality, accessibility, and focus on prevention before treatment through secure, localized, and sustainable cutting-edge technologies.
“Partnering with RapidAI aligns perfectly with our goal to transform and innovate on how care is delivered across our hospitals, from stroke to cardiac, vascular, and oncology, and to localize these capabilities for the Kingdom’s Vision 2030,” said Nasser Al Huqbani, CEO of Health Holdings Company.
Beyond Alerts: Actionable Intelligence at Scale
The foundation of this deployment is the Rapid Enterprise™ Platform, driven by RapidAI’s deep clinical AI. This technology goes beyond traditional alerts to provide characterization, quantification, visualization, and longitudinal tracking across entire disease states and service lines.
Built on advanced foundation models trained on multimodal clinical data, the platform integrates imaging, reports, and structured clinical data from real-world patient cases. This enables clinicians to make faster, more informed decisions and creates the groundwork for scalable, data-driven innovation throughout HHC’s entire healthcare system.
The platform, which is already the most clinically validated AI platform in healthcare, is used by over 2,500 hospitals in more than 100 countries. Implementation across HHC’s clusters will be supported by Ascend Solutions, a local digital solutions provider, ensuring tailored operational services, training, and optimization.
Karim Karti, CEO of RapidAI, highlighted the scope: “Together with HHC, we’re building the infrastructure for country-wide AI-enabled care that reflects the vision and ambition of Vision 2030.”
